Industries > Pharma > The Next Generation Sequencing Market Forecast 2019-2029

The Next Generation Sequencing Market Forecast 2019-2029

Drug Discovery, Genetic Screening, Diagnostics, Personalized Medicine, Agriculture and Animal Research, Infectious Diseases, Whole-Genome Sequencing, Targeted Re-Sequencing, Exome Sequencing, RNA Seq, Chip Seq, De Novo Sequencing, Methyl Seq, Instruments, Reagents & Consumables, Services, Hospital & Healthcare Institution, Academics, Biotechnology, Pharmaceutical, Others

PUBLISHED: 27 March 2019
PAGES: 209
PRODUCT CODE: PHA0379

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE

The next generation sequencing market is estimated to have reached $7bn in 2018. Both genetic screening and diagnostic segments dominated the next generation sequencing market in 2018.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Revenue forecast to 2029 of the Global Next Generation Sequencing Market by Application:
• Drug Discovery
• Genetic Screening
• Diagnostics
• Personalized Medicine
• Agriculture and Animal Research
• Infectious Diseases
• Others

Revenue forecast to 2029 of the Global Next Generation Sequencing Market by Technology:
• Whole-Genome Sewuencing
• Targeted Re-Sequencing
• Exome Sequencing
• RNA Seq
• Chip Seq
• De Novo Sequencing
• Methyl Seq
• Others

Revenue forecast to 2029 of the Global Next Generation Sequencing Market by Product:
• Instruments
• Reagents & Consumables
• Services

Revenue forecast to 2029 of the Global Next Generation Sequencing Market by End User:
• Hospital & Healthcare Institution
• Academics
• Biotechnology
• Pharmaceutical
• Others

• Revenue forecast to 2029 of the Global Next Generation Sequencing Market by Regional and National Market:

• North America
• US
• Canada

• Latin America
• Brazil
• Mexico
• Rest of Latin America

• Europe
• Germany
• The UK
• Italy
• France
• Spain
• Russia
• Rest of Europe

• Asia-Pacific

• Japan
• China
• India
• Australia & New Zealand
• ASEAN
• South Korea
• Rest of Asia-Pacific

• MEA
• GCC Countries
• Israel
• Rest of Middle East

• Africa
• South Africa
• Central Africa
• North Africa

Each regional market is further segmented by submarkets.

The report also includes profiles and for some of the leading companies in the Next Generation Sequencing market, with a focus on this segment of these companies’ operations:
• Agilent Technologies, Inc.
• BGI (Beijing Genomics Institute)
• Eurofins Scientific
• F. Hoffmann-La Roche AG
• Illumina, Inc
• Macrogen, Inc
• Oxford Nanopore Technologies, Ltd
• Pacific Biosciences of California, Inc.
• PerkinElmer, Inc.
• Qiagen N.V.
• Thermo Fisher Scientific Inc

Get our report today The Next Generation Sequencing Market Forecast 2019-2029: Drug Discovery, Genetic Screening, Diagnostics, Personalized Medicine, Agriculture and Animal Research, Infectious Diseases, Whole-Genome Sequencing, Targeted Re-Sequencing, Exome Sequencing, RNA Seq, Chip Seq, De Novo Sequencing, Methyl Seq, Instruments, Reagents & Consumables, Services, Hospital & Healthcare Institution, Academics, Biotechnology, Pharmaceutical, Others.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for The Next Generation Sequencing Market Forecast 2019-2029


Download sample pages

Complete the form below to download your free sample pages for The Next Generation Sequencing Market Forecast 2019-2029


Latest Pharma news

“Global Influenza Vaccines Market Set to Grow to $4.9bn by 2024” says new Visiongain report

The global vaccines market is one that is driven by innovation. This is vital for maintaining the rich pipeline of vaccines seen in the human vaccines market.

05 July 2019

READ

“Pharmaceutical Wholesale & Distribution Organizations 2019 is estimated to reach $1.4bn in 2024” says Visiongain report

Opportunities in the market stem from the increasing use of specialist and generic drugs, which have higher profit margins; global expansion into the emerging markets; vertical integration of wholesalers; and the increasing use of pharmaceuticals.

28 June 2019

READ

“Global Vaccines Sales market set to grow to $75bn by 2024” says new Visiongain report

Progress in R&D in the therapeutic vaccine field will yield revolutionary results and answer unmet medical needs. This will also lead to more innovative approaches to vaccine development.

25 June 2019

READ

“Global Inflammatory Bowel Diseases (IBD) Drug Market is estimated to reach $8.6bn by 2024” says new Visiongain report

Revenue growth will be driven by rising incidence and prevalence owing to modern lifestyles and improved awareness and diagnosis.

21 June 2019

READ

Categories

Category